Trademark Alertz ®
Search
Trademark
Owner
Trademark: ADAPTIVE THERAPEUTICS 1744111
Word
ADAPTIVE THERAPEUTICS
ID
1744111
Trademark Type
Word
Status
Withdrawn: Cancelled before protection
Application Date
17 November 2015
Owner(s)
Adaptive Biotechnologies Corporation
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 42
:
Scientific and technological services and research and design relating thereto
;
scientific research, development, engineering, testing, scientific research consultation, and analytical services in the fields of medicine, oncology, hematology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune sequencing, immune repertoire quantitation and sequencing, diagnostics, pharmaceuticals, genetics, gene expression, genetics testing, vaccines and vaccine development, biotechnology, T-cell therapeutics, antibody development and therapeutics, and therapeutic technologies
;
development of new technology for others in the fields of medicine, oncology, hematology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune sequencing, immune repertoire quantitation and sequencing, diagnostics, pharmaceuticals, genetics, genetics testing, vaccines and vaccine development, biotechnology, T-cell therapeutics, antibody development and therapeutics, and therapeutic technologies
;
DNA screening and analysis services
;
genome amplification
;
genotyping services for research or analysis purposes
;
medical and scientific research in the fields of cancer biology and diagnosing and treating cancer
;
providing medical and scientific research information in the field of clinical trials
;
scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample
;
scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample
;
scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor
;
scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
;
research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
;
scientific research, development, engineering, testing, and analytical services for identifying polypeptide pairs of adaptive immune receptor heterodimers of the immune system
;
scientific research, development, engineering, testing, and analytical services for analyzing and quantifying the diversity of the immune system
;
scientific research, development, engineering, testing, and analytical services for discovering immune targets
;
scientific research, engineering, testing, and analytical services for developing monoclonal antibodies and epitope mapping
;
scientific research for providing sequencing data and analysis of the immune system for vaccine development and vaccine optimization
;
research and development of vaccines, immunotherapies, and diagnostics
;
providing technology consultation and research services in the field of immune repertoire analysis, personalized medicine, vaccines, immunotherapies, and diagnostics
;
scientific research for providing computational analysis of the immune repertoire
;
providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies
;
providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency
;
providing assays for tracking clones in an immune repertoire over time
;
providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly
;
research, development, engineering, testing, and analytical services in the fields of vaccines, screening and detecting diseases, medicine, and therapeutics
;
research and development of vaccines, immunotherapies, medical diagnostics kits, and therapeutics
;
research and development of diagnostic test kits for screening and detecting diseases
;
laboratory research and testing services relating to vaccines, screening and detecting diseases, medicine, and therapeutics
;
computer services
;
design and development of computer hardware and software
;
computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for screening and detecting diseases, and the analysis, evaluation, and reporting of those test results to healthcare professionals and patients
;
research and diagnostic services for identifying antigen-specific T cells for therapeutic use
Class 44
:
Medical services
;
medical analysis and diagnostic services
;
medical diagnostic services, namely, medical testing for diagnostic or treatment purposes
;
medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services
;
providing medical diagnostic testing for the treatment of cancer
;
providing medical testing for immune responses to immunotherapy or cancer treatment
;
providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes
;
medical testing for the prognosis and staging of patients with solid tumors for treatment purposes
;
therapeutic services
;
therapeutic services for the treatment of diseases
;
therapeutic services for the treatment of cancer